RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 287-294

  Tallini, Giovanni ^a   Santoro, Massimo ^b   Helie, Mary ^a   Carlomagno, Francesca ^b   Salvatore, Giuliana ^b   Chiappetta, Gennaro ^c   Carcangiu, Maria Luisa ^a   Fusco, Alfredo ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER GENETICS; CANCER GROWTH; CHILD; FEMALE; GENE ACTIVATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE RET; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID PAPILLARY CARCINOMA; UNDIFFERENTIATED CARCINOMA;

ADOLESCENT; ADULT; AGE FACTORS; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DROSOPHILA PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; ISOMERISM; MALE; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RISK FACTORS; THYROID NEOPLASMS;

EID: 0031933680     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Rosai, J., Carcangiu, M. L., and DeLellis, R. A. Tumors of the thyroid gland. In: Atlas of Tumor Pathology, 3rd series, fascicle 5. Washington DC: Armed Forces Institute of Pathology, 1992.
2. Carcangiu, M. L., Zampi, G., and Rosai. J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma." Am. J. Surg. Pathol., 8: 655-668, 1984.
3. Takahashi, M., Buma, Y., Iwamoto, T., Inaguma, Y., Ikeda, H., and Hiai, H. Cloning and expression of the ret protooncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene, 3: 571-578, 1988.
4. Treanor, J. J. S., Goodman, L., de Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., Gray, C., Armanini, M. P., Pollock, R. A., Hefti, F., Phillips, H. S., Goddard, A., Moore, M. W., Buj-Bello, A., Davies, A. M., Asai, N., Takahashi, M., Vandlen, R., Henderson, C. E., and Rosenthal, A. Characterization of a multicomponent receptor for GDNF. Nature (Lond.), 38: 280-283, 1996.
5. Jing, S., Wen, D., Yu, Y., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., Louis, J. C., Hu, S., Altrock, B. W., and Fox, G. M. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell, 85: 1113-1124, 1996.
6. Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F., and Pachnis, V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature (Lond.), 367: 380-383, 1994.
7. Smith, D. P., Eng, C., and Ponder, B. A. J. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease. J. Cell Sci., 18: 43-49, 1994.
8. Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R,. Bongarzone, I., Pierotti, M. A., Della Porta, G., Fusco, A., and Vecchio, G. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell, 60: 557-563, 1990.
9. Bongarzone, I., Monzini, N., Borrello, M. G., Carcano, C., Ferraresi, G., Arighi, E., Mondellini, P., Della Porta, G., and Pierotti, M. A. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine-kinase and the regulatory subunit RI alpha of cyclic AMP protein kinase A. Mol. Cell. Biol., 13: 358-366, 1993.
10. Santoro, M., Dathan, N. A., Berlingieri, M. T., Bongarzone, I., Paulin, C., Grieco, M., Pierotti, M. A., Vecchio, G., and Fusco, A. Molecular characterization of RET/PTC3: a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene, 9: 509-516, 1994.
11. Bongarzone, I., Butti, M. G., Coronelli, S., Borrello, M. G., Santoro, M., Mondellini, P., Pilotti, S., Fusco, A., Della Porta, G., and Pierotti, M. A. Frequent activation of Ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res., 54: 2979-2985, 1994.
12. Lanzi, C., Borrello, M. G., Bongarzone, I., Migliazza, A., Fusco, A., Grieco, M., Santoro, M., Gambetta, R. A., Zunino, F., Della Porta, G., and Pierotti, M. A. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Oncogene, 7: 2189-2194, 1992.
13. Bongarzone, I., Pierotti, M. A., Monzini, N., Mondellini, P., Manenti, G., Donghi, R., Pilotti, S., Grieco, M., Santoro, M., Fusco, M., Vecchio, G., and Della Porta, G. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene, 4: 1457-1462, 1989.
14. Ishizaka, Y., Kobayashi, S., Ushijima, T., Sugimura, T., and Nagao, M. Detection of ret/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene. 6: 1667-1672, 1991.
15. Jhiang, S. M., Caruso, D. R., Gilmore, E., Ishizaka, Y., Tahira, T., Nagao, M., and Mazzaferri, E. L. Detection of the PTC/ret oncogene in human thyroid cancers. Oncogene, 7: 1331-1337, 1992.
16. Wajjwalku, W., Nakamura, S., Hasegawa, Y., Miyazaki, K., Satoh, Y., Funahashi, H., Matsuyama, M., and Takahashi, M. Low frequency of rearrangement of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn. J. Cancer Res., 83: 671-675, 1992.
17. Santoro, M., Carlomagno, F., Hay, I. D., Herrmann, M. A,. Grieco, M., Melillo, R. M., Bongarzone, I., Pierotti, M. A., Della Porta, G., Berger, N., Peix, J. L., Paulin, C., Fabien, N., Vecchio, G., Jenkins, R. B., and Fusco, A. RET oncogene activation in human thyroid neoplasms is restricted to the papillary carcinoma subtype. J. Clin. Invest., 89: 1517-1522, 1992.
18. Sugg, S. L., Zheng, L. Rosen, I. B., Freeman, J. L., Ezzat, S., and Asa, S. L. RET/PTC-1, -2 and -3 oncogene rearrangements in human thyroid carcinomas: implication for metastatic potential? J. Clin. Endocrinol. Metab., 81: 3360-3365, 1996.
19. Williams, G. H., Rooney, S., Thomas, G. A., Cummins, G., and Williams, E. D. RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br. J. Cancer, 74: 585-589, 1996.
20. Santoro, M., Wong, W. T., Aroca, P., Santos, E., Matoskova, B., Grieco, M., Fusco, A., and Di Fiore, P. P. An epidermal growth factor receptor/Ret chimera generates mitogenic and transforming signals: evidence for a Ret-specific signaling pathway. Mol. Cell. Biol., 14: 663-675, 1994.
21. Carlomagno, F., De Vita, G., Berlingieri, M. T., De Franciscis, V., Melillo, R. M., Colantuoni, V., Kraus, M. H., Di Fiore, P. P., Fusco, A., and Santoro, M. Molecular heterogeneity of Ret loss of function in Hirschsprung's disease. EMBO J., 15: 2717-2725, 1996.
22. Viglietto, G., Chiappetta, G., Fukunaga, F. H., Visconti, R., Mastro, A., Rigopoulou, D., Martinez-Tello, F. J., Tallini, G., Santoro, M., and Fusco, A. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene, 11: 1207-1210, 1995.
23. Santoro, M., Chiappetta, G., Cerrato, A., Salvatore, D., Zhang, L., Manzo, G., Picone, A., Portella, G., Santelli, G., Vecchio, G., and Fusco, A. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene, 12: 1821-1826, 1996.
24. Ercolani, L., Florence, B., Denaro, M., and Alexander, M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem., 263: 15335-15341, 1988.
25. Fabien, N., Paulin, C., Santoro, M., Berger, N., Grieco, M., Galvain, D., Barbier, Y., Dubois, P. M., and Fusco, A. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridization. Br. J. Cancer, 66: 1094-1098, 1992.
26. Santoro, M., Grieco, M., Melillo, R. M., Fusco, A., and Vecchio, G. Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation. Eur. J. Endocrinol., 133: 513-522, 1995.
27. Klugbauer, S., Lengfelder, E., Demidchik, E. P., and Rabes, H. M. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene, 11: 2459-2467, 1995.
28. Fugazzola, L., Pilotti, S., Pinchera, A., Vorontsova, T. V., Mondellini, P., Bongarzone, I., Greco, A., Astakhova, L., Butti, M. G., Demidchik, E. P., Pacini, F., and Pierotti, M. A. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res., 55: 5617-5620, 1995.
29. Cady, B., Rossi, R., Silverman, M., and Wool, M. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery, 98: 1171-1178, 1985.
30. Zedenius, J., Wallin, G., Svensson, A., Bovee, J., Hoog, A., Backdahl, M., and Larsson, C. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum. Genet., 97: 299-303, 1996.
31. Herrmann, M. A., Hay, I. D., Bartelt, D. H., Ritland, S. R., Dahl, R. J., Grant, C. S., and Jenkins, R. B. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J. Clin. Invest., 88: 1596-1604, 1991.
32. Roque, L., Castedo, S., Clode, A., and Soares, J. Deletion of 3p25-pter in a primary follicular thyroid carcinoma and its metastasis. Genes Chromosomes Cancer, 8: 199-203, 1993.
33. Jhiang, S. M., Sagaritz, J. E., Tong, Q., Parker-Thornburg, J., Capen, C. C., Cho, J. Y., Xing, S., and Ledent, C. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology, 137: 375-378, 1996.
34. Santoro, M., Sabino, M., Ishizaka, Y., Ushijima, T., Carlomagno, F., Cerrato, A., Grieco, M., Battaglia, C., Martelli, M. L., Paulin, C., Fabien, N., Sugimura, T., Fusco, A., and Nagao, M. Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Br. J. Cancer, 68: 460-464, 1993.
35. Williams, D. Chernobyl, eight years on. Nature (Lond.), 371: 556, 1994.
36. Ito, T., Seyama, T., Iwamoto, K. S., Hayashi, T., Mizumo, T., Tsuyama, N., Dohi, K., Nakamura, N., and Akiyama, M. In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res., 53: 2940-2943, 1993.
37. Fagin, J. A. Genetic basis of endocrine disease. 3. Molecular defects in thyroid gland neoplasia. J. Clin. Endocrinol. Metab., 75: 1398-1400, 1992.
38. Greco, A., Pierotti, M. A., Bongarzone, I., Pagliardini, S., Lanzi, C., and Della Porta, G. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene, 7: 237-242, 1992.
39. Di Renzo, M. F. F., Olivero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Costantino, A., Vigneri, R., Pierotti, M. A., and Comoglio, P. M. Overexpression of the c-MET/HGF-receptor gene in human thyroid carcinomas. Oncogene, 7: 2549-2553, 1992.
40. Hara, H., Fulton, N., Yashiro, T., Ito, K., DeGroot, L. J., and Kaplan, E. L. N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery, 116: 1010-1016, 1994.